Brief: Medincell Says Uzedy Net Sales Increased 63% To $191 Million In 2025
28/01/2026 13:12
Jan 28 (Reuters) - Medincell SA MEDCL.PA: UZEDY NET SALES INCREASED 63% TO $191 MILLION IN 2025 SUBMISSION OF OLANZAPINE LAI IN EUROPEAN UNION FOR TREATMENT OF SCHIZOPHRENIA IN ADULTS IS EXPECTED IN Q2 2026 RECEIVES MID‑TO HIGH‑SINGLE-DIGIT ROYALTIES ON UZEDY NET SALES AND IS ELIGIBLE FOR UP TO $105 MILLION IN COMMERCIAL MILESTONE PAYMENTS TEVA PROJECTS 2026 NET SALES OF $250-$280 MILLION Source text: ID:nBw6Vsplba Further company coverage: MEDCL.PA (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))